Pancreatic adenocarcinoma versus chronic pancreatitis: Differentiation with triple-phase helical CT

Abdominal Imaging

Volumn 35, Issue 2, 2010, Pages 163-171

  Yamada, Yasunari ^a   Mori, Hiromu ^a   Matsumoto, Shunro ^a   Kiyosue, Hiro ^a   Hori, Yuko ^a   Hongo, Norio ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Chronic pancreatitis; Computed tomography; Differential diagnosis; Pancreatic adenocarcinoma; Timeattenuation curves

Indexed keywords

IOHEXOL; IOPAMIDOL;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IOHEXOL; IOPAMIDOL; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 77953477612     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-009-9579-7     Document Type: Article

References (34)

1. Chijiwa K, Saiki S, et al. (1996) "Mass-forming" pancreatitis masquerades as pancreatic carcinoma. Int J Pancreatol 20:27-35
2. Steer ML, Waxman I, Freedman S (1995) Chronic pancreatitis. N Engl J Med 332:1482-1490
3. Bramhall SR, Allum WH, Jones AG, et al. (1995) Treatment and survival in 13, 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 82:111-115
4. Smith CD, Behrns KE, van Heerden JA, et al. (1994) Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg 81:585-589
5. Tajima Y, Kuroki T, Tsutsumi R, Kim T, et al. (2007) Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 13:858-865
6. Kim JK, Altun E, Elias J, et al. (2007) Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging 26:313-322
7. Ichikawa T, Sou H, Araki T, et al. (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107-116
8. Lu DSK, Vedantham S, Krasney RM, et al. (1996) Two-phase helical CT for pancreatic tumors: pancreatic and hepatic phase enhancement of tumor, pancreas and vascular structures. Radiology 199:697-701
9. Fletcher JG, Wiersema MJ, Farrel MA, et al. (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229:81-90
10. Zeman RK, Silverman PM, Ascher SM, et al. (1995) Helical (spiral) CT of the pancreas and biliary tract. Radiol Clin North Am 33:887-902
11. Tublin ME, Tessler FN, Cheng AL, et al. (1999) Effect of injection rate of contrast medium on pancreatic and hepatic helical CT. Radiology 210:97-101
12. Schlieman MG, Ho HS, Bold RJ (2003) Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg 138:951-955
13. Yoshida K, Toki F, Takeuchi T, et al. (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561-1568
14. Okazaki K, Uchida K, Ohara M, et al. (2000) Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118:573-581
15. Yang DH, Kim KW, Kim TK, et al. (2006) Autoimmune pancreatitis: radiologic findings in 20 patients. Abdom Imaging 31:94-102
16. Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381-385
17. Diehl S, Lehmann K, Sadick M, et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing respectability. Radiology 206:373-378
18. Tabuchi T, Itoh K, Ohshio G, et al. (1999) Tumor staging of pancreatic adenocarcinoma using early and late-phase helical CT. AJR Am J Roentgenol 173:375-380
19. Vargas R, Nino-Murcia M, Trueblood W, et al. (2004) MDCT in pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 182:419-425
20. Kim T, Murakami T, Takamura M, et al. (2001) Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol 177:367-371
21. Furukawa H, Takayasu K, Mukai K, et al. (1996) Late contrast-enhanced CT for small pancreatic carcinoma: delayed enhanced area on CT with histopathological correlation. Hepatogastroen-terology 43:1230-1237
22. Demachi H, Matsui O, Kobayashi S, et al. (1997) Histological influence on contrast-enhanced CT of pancreatic ductal adeno-carcinoma. J Comput Assist Tomogr 21:980-985
23. Kim T, Murakami T, Takahashi S, et al. (1998) Effect of injection rates of contrast material on arterial phase hepatic CT. AJR Am J Roentgenol 171:429-432
24. Awai K, Hori S (2003) Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 13:2155-2160
25. Itoh S, Satake H, Ohta T, et al. (2002) Pancreatic ductal adeno-carcinoma showing iso-attenuation in early-phase contrast-enhanced CT: comparison with histopathological findings. Radiat Med 20:59-67
26. Boland GW, O'Malley ME, Saez M, et al. (1999) Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma. AJR Am J Roentgenol 172:605-608
27. McNulty NJ, Francis IR, Platt JF, et al. (2001) Multi-detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vascula-ture, and pancreatic adenocarcinoma. Radiology 220:97-102
28. Tajima Y, Matsuzaki S, Furui J, et al. (2004) Use of the time-signal intensity curve from dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis after pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy. Br J Surg 91:595-600
29. Cubilla AL, Fitzgerald PJ (1984) Tumors of the exocrine pancreas. In: Atlas of tumor pathology. 2nd ed, vol 19, Washington, DC: Armed Forces Institute of Pathology, pp 1-40
30. Kuniyasu H, Abburuzzese JL, Cleary KR, et al. (2001) Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int J Oncol 19:681-685
31. De Angelis C, Valente G, Spaccapietra M, et al. (1992) Histological study of alcoholic, nonalcoholic, and obstructive chronic pancreatitis. Pancreas 7:193-196
32. Schilling MK, Redaelli C, Reber PU, et al. (1999) Microcirculation in chronic pancreatitis: a laser Doppler flow study. Pancreas 19:21-25
33. Lewis MP, Lo SK, Reber PU, et al. (2000) Endoscopic measurement of pancreatic tissue perfusion in patients with chronic pancreatitis and control patients. Gastrointest Endosc 51:195-199
34. Tsuda T, Mochizuki T, Kikuchi K, et al. (2001) Late-phase enhancement of the upstream portion of pancreatic adenocarci-noma on dual-phase helical CT. Abdom Imaging 26:635-639